Collectively, our results contribute to a broader comprehension of the mechanisms driving RCC tumorigenesis, highlighting potential molecular pathways involving RSK4, RUNX1, and EPHA2 in the specific context of RCC cell lines. This evidence concerns the gene RUNX1 and renal cell carcinoma.